PYRROLIDINE GPR40 MODULATORS FOR THE TREATMENT OF DISEASES SUCH AS DIABETES

The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medic...

Full description

Saved in:
Bibliographic Details
Main Authors JURICA, ELIZABETH A, HONG, ZHENQIU
Format Patent
LanguageEnglish
French
Published 27.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments. La présente invention concerne des composés de formule (I) ou un stéréo-isomère, un tautomère, un sel pharmaceutiquement acceptable, un polymorphe ou un solvate desdits composés, toutes les variables de la formule étant telles que définies dans la description. Ces composés sont des modulateurs du récepteur couplé aux protéines G GPR40, qui peuvent être utilisés en tant que médicaments.
AbstractList The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments. La présente invention concerne des composés de formule (I) ou un stéréo-isomère, un tautomère, un sel pharmaceutiquement acceptable, un polymorphe ou un solvate desdits composés, toutes les variables de la formule étant telles que définies dans la description. Ces composés sont des modulateurs du récepteur couplé aux protéines G GPR40, qui peuvent être utilisés en tant que médicaments.
Author HONG, ZHENQIU
JURICA, ELIZABETH A
Author_xml – fullname: JURICA, ELIZABETH A
– fullname: HONG, ZHENQIU
BookMark eNrjYmDJy89L5WTwDogMCvL38XTx9HNVcA8IMjFQ8PV3CfVxDPEPClZw8w9SCPFwVQgJcnUM8XX1C1Hwd1Nw8Qx2dQx2DVYIDnX2UHAMBgo4OrmGuAbzMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjSxMLQzNDZ2PCKgDzMy5m
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES PYRROLIDINE MODULATEURS DE GPR40 POUR LE TRAITEMENT DE MALADIES TELLES QUE LE DIABETE
ExternalDocumentID CA2948161C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2948161C3
IEDL.DBID EVB
IngestDate Fri Aug 02 08:59:32 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2948161C3
Notes Application Number: CA20152948161
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201027&DB=EPODOC&CC=CA&NR=2948161C
ParticipantIDs epo_espacenet_CA2948161C
PublicationCentury 2000
PublicationDate 20201027
PublicationDateYYYYMMDD 2020-10-27
PublicationDate_xml – month: 10
  year: 2020
  text: 20201027
  day: 27
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.2925456
Snippet The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PYRROLIDINE GPR40 MODULATORS FOR THE TREATMENT OF DISEASES SUCH AS DIABETES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201027&DB=EPODOC&locale=&CC=CA&NR=2948161C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fT8IwEL4gGvVNUYO_-2D2tji6ssHDYkbXORTYshWDT4SVLfgyiMz479suoL7w1lyTy-WS--6u7X0FeDCEsHKzK3RhEqETy5Q42MpTHdtznLdTRQCiBpyHIysYk5dJe1KDxXYWpuIJ_a7IEWVECRnvZYXXq79DLK96W7l-TD-kaPnkc8fTNt2xutrFtub1HBaFXkg1Sh3qaqPYwYqVxGrRPdhXRbRi2WdvPTWTsvqfUPwTOIikrqI8hVpWNOCIbv9da8DhcHPdLZebyFufwWv0HsfhoO_1Rww9RzEx0DD0xgOXh3GCZCuHeMAQj5nLFT0_Cn3k9RPmSrhEyZgGyE2kwO0xzpJzuPcZp4EurZr-OmBK3a355gXUi2WRNQHhHM9NLMsbI5-TGbHTDulgM8uF6JpdYza7hOYuLVe7t67hWLlRoTO2b6Befn5ltzLtluld5bEfM9yAfg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvGmqMEnezC9NcK2tHBoTNlubaWvtIvBE6GljV4KkRr_vrsNqBdum9lkMplkvpnZ3fkW4KGXZVqhjDI5U9RMVjWF42C_SGWsL3ExSAUBiBhw9gPNmaovs8GsAe-7WZiaJ_S7JkfkEZXxeK9qvF7_HWJZ9dvKzWP6wUWrJ5sZlrTtjsXVLtYla2zQKLRCIhFiEFMKYgMLVhKtTw7gUBfcvKJweh2LmZT1_4Rin8JRxHWV1Rk08rINLbL7d60Nx_72upsvt5G3OYdJ9BbHoedabkDRcxSrPeSH1tQzWRgniLdyiDkUsZiaTNDzo9BGlptQk8MlSqbEQWbCBeaYMppcQNemjDgyt2r-64A5MXfmK5fQLFdl3gGEC7xUMC9vesVSXah6OlSHWMmLLBspo95icQWdfVqu9291oeUw35t7bjC5gRPhUoHUWL-FZvX5ld_xFFyl97X3fgBe4YNr
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRROLIDINE+GPR40+MODULATORS+FOR+THE+TREATMENT+OF+DISEASES+SUCH+AS+DIABETES&rft.inventor=JURICA%2C+ELIZABETH+A&rft.inventor=HONG%2C+ZHENQIU&rft.date=2020-10-27&rft.externalDBID=C&rft.externalDocID=CA2948161C